Artisan Partners
IOVA icon

Artisan Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Artisan Partners’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,407,713
Closed -$14.7M – 362
2025
Q1 		$14.7M Sell
4,407,713
-134,455
-3% -$693K 0.02% 295
2024
Q4 		$33.6M Sell
4,542,168
-261,657
-5% -$2.43M 0.05% 269
2024
Q3 		$45.1M Sell
4,803,825
-307,584
-6% -$2.91M 0.07% 236
2024
Q2 		$41M Sell
5,111,409
-26,813
-0.5% -$287K 0.06% 246
2024
Q1 		$76.1M Buy
5,138,222
+310,552
+6% +$3.61M 0.11% 178
2023
Q4 		$39.2M Sell
4,827,670
-208,809
-4% -$1.09M 0.06% 236
2023
Q3 		$22.9M Buy
5,036,479
+609,738
+14% +$3.98M 0.04% 244
2023
Q2 		$31.2M Buy
4,426,741
+858,035
+24% +$6.14M 0.05% 237
2023
Q1 		$21.8M Buy
3,568,706
+832,974
+30% +$5.75M 0.04% 253
2022
Q4 		$17.5M Sell
2,735,732
-22,841
-0.8% -$178K 0.03% 262
2022
Q3 		$26.4M Sell
2,758,573
-20,229
-0.7% -$233K 0.05% 243
2022
Q2 		$30.7M Buy
2,778,802
+66,788
+2% +$875K 0.05% 238
2022
Q1 		$45.2M Buy
2,712,014
+24,284
+0.9% +$376K 0.06% 239
2021
Q4 		$51.3M Sell
2,687,730
-180,565
-6% -$3.98M 0.06% 245
2021
Q3 		$70.7M Sell
2,868,295
-106,039
-4% -$2.5M 0.09% 217
2021
Q2 		$77.4M Sell
2,974,334
-8,780
-0.3% -$228K 0.09% 206
2021
Q1 		$94.4M Buy
2,983,114
+79,645
+3% +$3.3M 0.12% 186
2020
Q4 		$135M Buy
2,903,469
+71,231
+3% +$2.83M 0.16% 143
2020
Q3 		$93.2M Sell
2,832,238
-157,915
-5% -$4.84M 0.13% 159
2020
Q2 		$82.1M Buy
2,990,153
+1,188,943
+66% +$39.1M 0.13% 155
2020
Q1 		$53.9M Buy
1,801,210
+156,093
+9% +$4.14M 0.12% 170
2019
Q4 		$45.5M Buy
1,645,117
+432,569
+36% +$9.84M 0.08% 193
2019
Q3 		$22.1M Buy
1,212,548
+177,152
+17% +$3.92M 0.04% 231
2019
Q2 		$25.4M Buy
+1,035,396
New +$15.6M 0.05% 223

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Artisan Partners's IOVA Position: Q2 2025 in Review

Artisan Partners sold out of Iovance Biotherapeutics (IOVA) in Q2 2025, closing a stake of 4,407,713 shares — an estimated $14.7M sold.

Artisan Partners first reported a position in IOVA in Q2 2019 and held it in 24 quarters. The position peaked at $135M in Q4 2020. 254 funds tracked by Wall St. Rank hold IOVA as of Q2 2025.

  • Artisan Partners reported no remaining Iovance Biotherapeutics position as of Q2 2025 after selling out during the quarter.
  • Artisan Partners sold 4,407,713 Iovance Biotherapeutics shares in Q2 2025, an estimated $14.7M.
  • Artisan Partners first reported a position in Iovance Biotherapeutics in Q2 2019 and held it in 24 quarters.
  • Artisan Partners's Iovance Biotherapeutics position peaked at $135M in Q4 2020.
  • 254 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2025.

Based on Artisan Partners's 13F filing for Q2 2025, filed 12 Aug 2025.